Multiple myeloma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 30: Line 30:
===Race===
===Race===
*Multiple myeloma usually affects individuals of the African American and Native Pacific Islanders race. Asian and Native Indian individuals are less likely to develop multiple myeloma.<ref>Multiple myeloma. Wikipedia (2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology Accessed on September, 20th 2015</ref>
*Multiple myeloma usually affects individuals of the African American and Native Pacific Islanders race. Asian and Native Indian individuals are less likely to develop multiple myeloma.<ref>Multiple myeloma. Wikipedia (2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology Accessed on September, 20th 2015</ref>
*Among African Americans, multiple myeloma is one of the top 10 leading causes of cancer deaths. <ref>Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015</ref>
*Among African Americans, multiple myeloma is one of the top 10 leading causes of cancer deaths.<ref>Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015</ref>


==Gallery==
==Gallery==

Revision as of 12:18, 23 September 2015

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma epidemiology and demographics

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma epidemiology and demographics

CDC on Multiple myeloma epidemiology and demographics

Multiple myeloma epidemiology and demographics in the news

Blogs on Multiple myeloma epidemiology and demographics

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

In 2012, the incidence of multiple myeloma was approximately 6.3 per 100,000 cases with a mortality rate of 3.3 per 100,000 cases in the United States.[1] The prevalence of multiple myeloma was estimated to be 89,658 cases in 2012 in the United States.[2][3] Multiple myeloma is the second most common blood cancer after non-Hodgkin's lymphoma & 14th most common cancer overall in United States.[4][5][6] Males are more commonly affected with multiple myeloma than females. The male to female ratio is approximately 1.54 to 1.[7][8] Multiple myeloma usually affects individuals of the African American and Native Pacific Islanders race. Asian individuals are less likely to develop multiple myeloma.[9] The incidence of multiple myeloma increases with age; the median age at diagnosis is between 65 to 70 years.[10]

Epidemiology and Demographics

Incidence

  • In 2012, the incidence of multiple myeloma waws approximately 6.3 per 100,000 individuals with a case-fatality rate of 3.3 per 100,000 in the United States.[11]
  • In 2014, multiple myeloma constituted approximately 1.4 percent of the estimated new cancer cases.[12]
  • In 2015, the estimated incidence of multiple myeloma is 1.6% of all new cancer cases and 1.9% of all cancer mortality cases.[13]
  • Multiple myeloma is the 14th leading cause of cancer death in the United States.[14]
  • Since 1975, the overall multiple myeloma incidence has increased nearly 1 percent annually.[15]

Prevalance

  • Myeloma is the 14th leading cause of cancer death in the United States.[16]
  • Multiple myeloma is the second most prevalent blood cancer (10%) after non-Hodgkin's lymphoma.[4][17]
  • There are approximately 76,000 people in the United States living with multiple myeloma. [18]
  • Multiple myeloma represents approximately 1% of all cancers and 2% of all cancer deaths.[19]
  • In 2012, there were an estimated 89,658 people living with multiple myeloma in the United States.[20]

Age

  • The incidence of multiple myeloma increases with age where the median age at diagnosis is is 65 to 70 years. Recent statistics concerning earlier age of onset in multiple myelom indicate an increase in incidence among the population.[21]
  • Multiple myeloma is a common malignancy of patients above 40 years old (70% of cases are diagnosed between 50 and 70 years of age.[22])

Gender

  • Male are more commonly affected with multiple myeloma than female. The male to female ratio is approximately 1.54 to 1.[23]

Race

  • Multiple myeloma usually affects individuals of the African American and Native Pacific Islanders race. Asian and Native Indian individuals are less likely to develop multiple myeloma.[24]
  • Among African Americans, multiple myeloma is one of the top 10 leading causes of cancer deaths.[25]

Gallery

Multiple myeloma summary.[26]


Percent of new cases by age group: multiple myeloma.[27]


Number of new cases per 100,000 persons by race/ethnicity & sex: multiple myeloma.[28]


Percent of deaths per age group: multiple myeloma.[29]


Number of deaths per 100,000 persons by race/ethnicity & sex multiple myeloma.[30]


Multiple myeloma percent of total new cancer csases in the United states.[31]


Five year survival percentage.[32]


New cases, deaths, and 5-Year relative survival.[33]

References

  1. Plasma cell neoplasm.National cancer institute (2015)http://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq#cit/section_1.1
  2. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  3. Multiple myeloma. Wikipedia (2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology
  4. 4.0 4.1 Collins, CD. (2005). "Problems monitoring response in multiple myeloma". Cancer Imaging. 5 Spec No A: S119–26. doi:10.1102/1470-7330.2005.0033. PMID 16361127.
  5. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  6. Multiple myeloma. Wikipedia (2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology Accessed on September, 20th 2015
  7. Multiplemyeloma.Wikipedia(2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology Accessed on September, 20th 2015
  8. Multiple myeloma. Radiopaedia (2015)http://radiopaedia.org/articles/multiple-myeloma-1 Accessed on September, 20th 2015
  9. Multiple myeloma. Wikipedia (2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology Accessed on September, 20th 2015
  10. Multiple myeloma. Wikipedia (2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology Accessed on September, 20th 2015
  11. Plasma cell neoplasm.National cancer institute (2015)http://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq#cit/section_1.1
  12. A snapshot of myeloma. National cancer institute(2014)http://www.cancer.gov/research/progress/snapshots/myeloma Accessed on September, 20th 2015
  13. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  14. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  15. A snapshot of myeloma. National cancer institute(2014)http://www.cancer.gov/research/progress/snapshots/myeloma
  16. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  17. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  18. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  19. Multiple myeloma. Wikipedia (2015) https://en.wikipedia.org/wiki/Multiple_myeloma. Accessed on September, 20th 2015
  20. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  21. Press Releases. Compugen (2015)http://www.cgen.com/media-center/press-releases/-314 Accessed on September, 20th 2015
  22. Multiple myeloma. Radiopaedia (2015)http://radiopaedia.org/articles/multiple-myeloma-1 Accessed on September, 20th 2015
  23. Multiple myeloma. Radiopaedia (2015)http://radiopaedia.org/articles/multiple-myeloma-1 Accessed on September, 20th 2015
  24. Multiple myeloma. Wikipedia (2015)https://en.wikipedia.org/wiki/Multiple_myeloma#Pathophysiology Accessed on September, 20th 2015
  25. Seer stat fact sheet. National cancer institute (2015)http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September, 20th 2015
  26. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015
  27. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015
  28. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015
  29. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015
  30. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015
  31. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015
  32. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015
  33. SEER Stat Fact Sheets: Myeloma. Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery.http://seer.cancer.gov/statfacts/html/mulmy.html Accessed on September ,20 2015

Template:WikiDoc Sources